Optimizing Brain Performance
with Applied NeuroScience

Uncover the cause of undesired symptoms due to specific brain abnormalities.

Clinical NeuroAnalytics

Clinical NeuroAnalytics provides a team approach to the optimization of brain performance through the use of applied NeuroScience. Our team consists of physicians with backgrounds in neurology, epileptology, psychiatry, and clinical brain science who are dedicated to uncovering the cause of undesired symptoms due to specific brain abnormalities.

The science uses Electroencephalogram (EEG) and quantitative EEG (qEEG) brain mapping technology, pharmacological treatment experience, behavioral health experience, family social clinical experience, and nearly 100 years of medication and brain electrical intervention yielding optimum behavior outcomes. This approach allows for a very specific, individualized clinical regimen that is designed to optimize a patient’s ability to function in today’s world. Most importantly, our process greatly reduces the chance of a patient experiencing poor medication response and failed therapy protocols.

Our Approach

We differ from others in the industry by providing consultation services and a comprehensive treatment plan with recommendations for NeuroFeedback, biofeedback, transcranial Direct Current Stimulation, Transcranial Magnetic Stimulation, additional physiological testing, as well as psychiatric medication recommendation.

Patients are often blindly prescribed medication based on their outward appearance, behavior, and actions with no actual reference to the source of their symptoms: the brain. By looking directly to the patient’s brain waves via EEG/qEEG technology, we are able to better recognize and locate the specific abnormalities causing the undesired symptoms and provide more successful treatment recommendations. This allows patients to bypass what could be months or years of misdiagnosis and medication failure leading to unchanging or regressive symptomology.

Do You Have a Family Member with a Traumatic Brain Injury?

1.  Gain an understanding of why past medications produced undesirable, ineffective, or no effects at all.

2.  Select a medication class optimized to the presenting neurological data, and

3.  Realize when medication may not be a clearly defined option.

EEG/qEEG Interpretation

Electroencephalography is an electrophysiological monitoring method to record electrical activity of the brain. Board Certified Electroencephalographers are neurologists and electrophysiologists that specialize in interpretation of the raw EEG data.

Many in our NeuroFeedback industry use qEEG brain mapping to guide their NeuroFeedback protocols; however, very few have their EEG data interpreted by a board certified electroencephalographer. We have found that without this electroencephalographer interpretation, particularly in those who have failed on multiple psychiatric medication attempts, there have been missed or unidentified abnormalities in their EEGs. Without identification of these findings, the patients would have continued to be misdiagnosed, mismedicated, and in at least one case, would have died.

For optimal treatment of psychiatric conditions, we must scientifically assess the organ we are treating by a qualified medical team.


In terms of children and adolescents, we have found that there is a higher prevalence of neurological abnormalities when compared to adults. This suggests that they are far more difficult to medicate and have more serious side effects. Thus, integrating Pharmaco-EEG into a psychiatric practice helps to avoid mis-medicating at least 1/3 of children and adolescents.


  • Swatzyna, RJ, Tarnow, JD, Turner, RP, Roark, AJ, MacInerney, EK, and Kozlowski, GP (2016). Isolated Epileptiform Discharges in Psychiatry: Outcomes in an integrative practice. Paper presentation at the 19th Biennial International Pharmaco-EEG Meeting, The Netherlands.
  • Swatzyna, R.J. & Roark, A.J. (2016). The Prevalence of Epileptiform Discharges in a Psychiatric Practice: A Study of Non-Epileptic Children, Adolescents, and Young Adults with Autism. Paper presented at the International Society for NeuroFeedback and Research Conference, September 2016, Orlando, Florida.
  • Swatzyna, R.J. & Gunkelman, J. (2016). The Utility of EEG/qEEG in Children and Ay of EEG/qEEG in Children and Adolescents with ADHD: Replication Study. Paper presented at the Applied Psychophysiology and Biofeedback 47th Annual Scientific Meeting March 12, 2016, Seattle, WA.
  • Swatzyna, R.J. & Gunkelman, J. (2015). Predicting Medication Failure Using Big Data. Paper presented at the Society for the Advancement of Brain Analysis 14th Annual Conference, Atlanta, Georgia.

Uncover the Cause of Undesired Symptoms